New drug cocktail shows promise in shrinking stomach tumors before surgery
NCT ID NCT04745988
First seen Apr 18, 2026 · Last updated May 01, 2026 · Updated 5 times
Summary
This study tests a combination of three drugs (lenvatinib, pembrolizumab, and FLOT chemotherapy) given before and after surgery for stomach cancer. The goal is to see if this approach can shrink tumors significantly or make them disappear completely. The study involves 43 adults with early-stage stomach cancer that has not spread.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center Hospital East
Kashiwa, Chiba, Japan
Conditions
Explore the condition pages connected to this study.